Corrigendum: Approach for delabeling beta-lactam allergy in children

R Sáenz de Santa María; G Bogas; M Labella; A Ariza; M Salas; I Doña; M J Torres

doi:10.3389/falgy.2023.1361973

Corrigendum: Approach for delabeling beta-lactam allergy in children

Front Allergy. 2024 Jan 12:4:1361973. doi: 10.3389/falgy.2023.1361973. eCollection 2023.

Authors

R Sáenz de Santa María^{1

2}, G Bogas^{1

2}, M Labella^{1

2}, A Ariza², M Salas^{1

2}, I Doña^#^{1

2}, M J Torres^#^{1

2

3

4}

Affiliations

¹ Allergy Unit, Hospital Regional Universitario de Málaga, Hospital Civil, Málaga, Spain.
² Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Hospital Civil, Málaga, Spain.
³ Nanostructures for Diagnosing and Treatment of Allergic Diseases Laboratory, Andalusian Center for Nanomedicine and Biotechnology-BIONAND, Parque Tecnológico de Andalucía, Málaga, Spain.
⁴ Departamento de Medicina, Universidad de Málaga, Facultad de Medicina, Málaga, Spain.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/falgy.2023.1298335.].

Keywords: anaphylaxis; beta-lactam; children; drug provocation test; maculopapular exanthema; skin test; urticaria.

Publication types

Published Erratum

Grants and funding

GB holds a contract from “Juan Rodes” program (JR18/00054) from the Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness [grants co-funded by European Social Fund (ESF)]. AA holds a Senior Postdoctoral Contract (RH-0099–2020) from Andalusian Regional Ministry of Health [cofunded by European Social Fund (ESF): “Andalucía se mueve con Europa”]. The present study has been funded by Instituto de Salud Carlos III through the project “PI21/00329” and co-funded by the European Union.